Neuroone Medical Technologies (NMTC) Enterprise Value (2017 - 2026)

Neuroone Medical Technologies (NMTC) has reported Enterprise Value for 10 consecutive years, with $24.4 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Enterprise Value fell 5.24% year-over-year to $24.4 million; the trailing twelve-month figure through Jun 2026 stood at $24.4 million (down 5.24% YoY), and the FY2025 full-year result was $29.1 million, changed 0.22% from the prior year.
• Enterprise Value slipped to $24.4 million in Q2 2026 per NMTC's latest filing, from $37.3 million in the prior quarter.
• Across five years, Enterprise Value topped out at $37.3 million in Q1 2026 and bottomed at $3.1 million in Q2 2022.
• Historically, Enterprise Value has averaged $22.5 million across 5 years, with a median of $24.4 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Enterprise Value tumbled 95.58% in 2022, then jumped 489.15% in 2023.
• Over 5 years, Enterprise Value stood at $11.8 million in 2022, then soared by 208.63% to $36.6 million in 2023, then slumped by 33.42% to $24.3 million in 2024, then surged by 42.23% to $34.6 million in 2025, then decreased by 29.48% to $24.4 million in 2026.
• According to Business Quant data, Enterprise Value over the past three periods registered $24.4 million, $37.3 million, and $34.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.